Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POMALYST vs PONATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

POMALYST vs PONATINIB: Safety Overview

Metric POMALYST PONATINIB
Total FAERS Reports 1,398 10,011
Deaths Reported 312 2,924
Death Rate 22.3% 29.2%
Hospitalizations 417 4,254
Average Patient Age 68.4 yrs 55.8 yrs
% Female Patients N/A 46.2%
FDA Approval Date N/A Apr 23, 2015
Manufacturer N/A Takeda Pharmaceuticals America, Inc.
Route N/A ORAL
Marketing Status N/A Prescription